1325 G Street, N.W.
Washington, DC 20005
The Law Offices of David A. Balto provides counsel to companies on a broad range of antitrust matters and frequently represents parties before the Antitrust Division of the Department of Justice, the Federal Trade Commission, Congress and state legislatures.
The Law Offices of David Balto counsels a wide variety of Fortune 500 companies, small business and consumer advocates on antitrust and consumer protection compliance, strategic alliances, distribution issues, mergers and joint ventures. With decades of antitrust practice in each of the enforcement agencies and private practice, we effectively represent a broad range of consumer organizations, generic pharmaceutical and medical device manufactures, healthcare providers, retailers, financial services and high technology firms. We are regularly involved in many of the most high-profile government antitrust investigations and cutting-edge class-action litigation. We frequently provide representation for parties in the most sophisticated matters before the Antitrust Division of the Department of Justice, the Federal Trade Commission, Congress and state legislatures.
David Balto wins John Helmuth Award from the Organization for Competitive Markets. Click here to read more.
August 17, 2015 - David Balto and James Kovacs discuss why DOJ should block the latest announced health insurance mergers. View Here.
July 24, 2015 - David Balto and James Kovacs published an article in Competition Policy International Antitrust Chronicle discussing current competition issues in healthcare provider merger antitrust. View Here.
July 23, 2015 - David Balto talks to Bloomberg TV about Anthem-CIGNA and antitrust implications of the health insurance mergers. View Here.
July 15, 2015 - David Balto is quoted in NYT article articulating the harmful practices of pharmacy benefit managers in specialty pharmacy. View Here.
February 19, 2015 - David Balto files an amicus brief on behalf of consumer groups supporting New Yorks fight against product hopping. View Here.
June 19, 2014 - David Balto testifies before the Department of Labor, ERISA Advisory Council on the need for fee and compensation disclosures by pharmacy benefit mangers. View Here.
March 7, 2014 - David Balto and James Kovacs release an evaluation of proposed Medicare regulations and their impact on pharmaceutical access and care. View Here.
September 17, 2013 - David Balto explains how State-sponsored Patent Trolls signal a new form of protectionism. View Here.
August 19, 2013 - David Balto questions whether the FTC can be both Prosecutor and Judge. View Here.
July 22, 2013 - David Balto appeals to Congress to act on the anti-competitive issue of Pay-for-Delay. View Here.
June 28, 2013 - David Balto calls on the FTC to fix the patent litigation mess and explains how to stop patent privateering. View Here.
June 21, 2013 - David Balto explains how Google's acquisition of Waze will help consumers rather than limit competition. View Here.
June 20, 2013 - David Balto authors letter to FTC Chairwoman Edith Ramirez on behalf of the National Retail Federation, Food Marketing Institute and the National Restaurant Association applauding FTC attention to Patent Troll issues and urging FTC consideration of technology end-users in future FTC actions. View here.
June 3, 2013 - David Balto discusses using antitrust laws to police patent privateering. View here.
May 31, 2013 - David Balto discusses with supermarket pharmacies better navigate the current and upcoming PBM legislation. View here.
May 23, 2013 - David Balto discusses how arbitration and voluntary commitments will better resolve the EU's issues with Google. View here.
May 23, 2013 - David Balto argues for using arbitration to solve Fair, Reasonable and Nondiscriminatory (FRAND) royalties. View here.
May 21, 2013 - David Balto discusses the lack of evidence in the DOJ's case on the Bazaarvocie Inc.-Power Review merger. View here.
May 17, 2013 - David Balto and Hal Singer discuss how the FCC should allocate the broadcasters' spectrum. View here.
May 9, 2013 - David Balto releases paper calling for increased vigilance and enforcement by the antitrust agencies to ensure that patent pools and similar collective pooling and IP licensing arrangements properly fulfill their procompetitive purposes for the benefit of licensors, licensees and consumers alike. View here.
April 12, 2013 - David Balto addresses the Hawaii Legislature on anti-mail order legislation. View here.
April 12, 2013 -- David Balto stresses that Congress and regulators shouldn't forget about patent privateering. View here.
April 12, 2013 -- David Balto discusses the interaction between antitrust laws and the goals of health reform. View here.
April 9, 2013 -- David Balto shows that "hot" documents don't always tell the whole story in antitrust cases. View here.
April 8, 2013 -- David Balto calls for the repeal of the McCarran-Ferguson Act, before it's too late. View here.
April 6, 2013 -- David Balto argues that Uniregistry's request for antitrust immunity is meaningless. View here.
April 5, 2013 -- David Balto offers public comments to the FTC and DOJ on patent assertion entities. View here.
April 5, 2013 -- David Balto argues the FTC should use its full panoply of powers to attack the patent troll problem. View here.
March 25, 2013 - David Balto offers testimony before the North Dakota legislature on PBM MAC legislation. View here.
February 22, 2013 -- David Balto and Brendan Coffman offer public comments on the FTC's proposed Consent Order with Motorola Mobility, LLC. View here.
February 19, 2013 -- David Balto and independent California pharmacies applaud Anthem Blue Cross's decision to suspend a mail order drug delivery requirement for HIV/AIDS patients in California. View here.